124 related articles for article (PubMed ID: 21240369)
21. Haloperidol: effect of long-term treatment on rat striatal dopamine synthesis and turnover.
Lerner P; Nosé P; Gordon EK; Lovenberg W
Science; 1977 Jul; 197(4299):181-3. PubMed ID: 17917
[TBL] [Abstract][Full Text] [Related]
22. Barbiturates and meprobamate: decreases in cathecholamine turnover of central dopamine and noradrenaline neuronal systems and the influence of immobilization stress.
Lidbrink P; Corrodi H; Fuxe K; Olson L
Brain Res; 1972 Oct; 45(2):507-24. PubMed ID: 4404488
[No Abstract] [Full Text] [Related]
23. Central actions of dopa and dopamine.
Sourkes TL
Rev Can Biol; 1972; 31():Suppl:153-68. PubMed ID: 4403289
[No Abstract] [Full Text] [Related]
24. Comparison of effects of drugs on dopamine metabolism in the substantia nigra and the corpus striatum of rat brain.
Westerink BH; Korf J
Eur J Pharmacol; 1976 Nov; 40(1):131-6. PubMed ID: 991922
[TBL] [Abstract][Full Text] [Related]
25. Nigrostriatal cell firing action on the dopamine transporter.
Rodriguez M; Gonzalez S; Morales I; Sabate M; Gonzalez-Hernandez T; Gonzalez-Mora JL
Eur J Neurosci; 2007 May; 25(9):2755-65. PubMed ID: 17561841
[TBL] [Abstract][Full Text] [Related]
26. The antiparkinsonian drug budipine stimulates the activity of aromatic L-amino acid decarboxylase and enhances L-DOPA-induced dopamine release in rat substantia nigra.
Biggs CS; Fisher A; Starr MS
Synapse; 1998 Nov; 30(3):309-17. PubMed ID: 9776134
[TBL] [Abstract][Full Text] [Related]
27. Increased activity and expression of tyrosine hydroxylase in the rat substantia nigra after chronic treatment with nomifensine.
Rodríguez-Gómez JA; Romero-Ramos M; Vizuete ML; Venero JL; Cano J; Machado A
Mol Pharmacol; 1997 Oct; 52(4):641-7. PubMed ID: 9380027
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum.
Nissbrandt H; Sundström E; Jonsson G; Hjorth S; Carlsson A
J Neurochem; 1989 Apr; 52(4):1170-82. PubMed ID: 2564423
[TBL] [Abstract][Full Text] [Related]
29. Effects of 6-hydroxydopamine lesions of the prefrontal cortex on tyrosine hydroxylase activity in mesolimbic and nigrostriatal dopamine systems.
Rosin DL; Clark WA; Goldstein M; Roth RH; Deutch AY
Neuroscience; 1992 Jun; 48(4):831-9. PubMed ID: 1352864
[TBL] [Abstract][Full Text] [Related]
30. Intranigral application of substance P antagonists prevents the haloperidol-induced activation of striatal tyrosine hydroxylase.
Melis MR; Gale K
Naunyn Schmiedebergs Arch Pharmacol; 1984 May; 326(1):83-6. PubMed ID: 6206401
[TBL] [Abstract][Full Text] [Related]
31. Increase of dopamine synthesis in synaptosomes from rats treated with neuroleptics or reserpine.
Tissari AH
Med Biol; 1982 Feb; 60(1):38-41. PubMed ID: 6121960
[TBL] [Abstract][Full Text] [Related]
32. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.
Lapchak PA; Beck KD; Araujo DM; Irwin I; Langston JW; Hefti F
Neuroscience; 1993 Apr; 53(3):639-50. PubMed ID: 8098137
[TBL] [Abstract][Full Text] [Related]
33. 3-Acetylpyridine-induced degeneration of the nigrostriatal dopamine system: an animal model of olivopontocerebellar atrophy-associated parkinsonism.
Deutch AY; Rosin DL; Goldstein M; Roth RH
Exp Neurol; 1989 Jul; 105(1):1-9. PubMed ID: 2568269
[TBL] [Abstract][Full Text] [Related]
34. Modulation of striatal enkephalinergic neurons by antipsychotic drugs.
Hong JS; Yoshikawa K; Kanamatsu T; Sabol SL
Fed Proc; 1985 Jun; 44(9):2535-9. PubMed ID: 3838946
[TBL] [Abstract][Full Text] [Related]
35. SCH 23390, a selective D1 dopamine receptor blocker, enhances the firing rate of nigral dopaminergic neurons but fails to activate striatal tyrosine hydroxylase.
Onali P; Mereu G; Olianas MC; Bunse B; Rossetti Z; Gessa GL
Brain Res; 1985 Aug; 340(1):1-7. PubMed ID: 2862956
[TBL] [Abstract][Full Text] [Related]
36. An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions.
Nagatsu T; Yoshida M
Neurosci Lett; 1988 Apr; 87(1-2):178-82. PubMed ID: 2898112
[TBL] [Abstract][Full Text] [Related]
37. Dopamine release in rat striatum: physiological coupling to tyrosine supply.
During MJ; Acworth IN; Wurtman RJ
J Neurochem; 1989 May; 52(5):1449-54. PubMed ID: 2496199
[TBL] [Abstract][Full Text] [Related]
38. Neonatal methamphetamine in the rat: evidence for gender-specific differences upon tyrosine hydroxylase enzyme in the dopaminergic nigrostriatal system.
Gomes-da-Silva J; Perez-Rosado A; de Miguel R ; Fernandez-Ruiz J; Silva MC; Tavares MA
Ann N Y Acad Sci; 2000 Sep; 914():431-8. PubMed ID: 11085342
[TBL] [Abstract][Full Text] [Related]
39. Reserpine pretreatment prevents increases in extracellular striatal dopamine following L-DOPA administration in rats with nigrostriatal denervation.
Kannari K; Tanaka H; Maeda T; Tomiyama M; Suda T; Matsunaga M
J Neurochem; 2000 Jan; 74(1):263-9. PubMed ID: 10617128
[TBL] [Abstract][Full Text] [Related]
40. Effects of chronic haloperidol on vitamin E levels and monoamine metabolism in rats fed normal and vitamin E deficient diets.
VonVoigtlander PF; Burian MA; Althaus JS; Williams LR
Res Commun Chem Pathol Pharmacol; 1990 Jun; 68(3):343-52. PubMed ID: 2385757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
